Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Sevilla Mambrilla, Arrate; Sánchez-Diez, Ana; Cobo Sustacha, Sofía; Izagirre Arribalzaga, Neskuts; Martinez-Cadenas, Conrado; Marti, Rosa M; Puértolas, Teresa; De Unamuno Bustos, Blanca; Bañuls, José; Izu, Rosa; Gardeazabal, Jesús; Asumendi, Aintzane; Boyano, María D.; Alonso, Santos
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Association of TYR SNP rs1042602 with Melanoma Risk and PrognosisAutoría
Fecha de publicación
2023Editor
MDPICita bibliográfica
Sevilla, A.; Sánchez-Diez, A.; Cobo, S.; Izagirre, N.; Martinez-Cadenas, C.; Martí, R.M.; Puértolas, T.; de Unamuno, B.; Bañuls, J.; Izu, R.; et al. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis. Life 2022, 12, 2004. https://doi.org/10.3390/ life12122004Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://www.mdpi.com/2075-1729/12/12/2004Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Cutaneous melanoma is the most aggressive of skin tumors. In order to discover new
biomarkers that could help us improve prognostic prediction in melanoma patients, we have searched
for germline DNA variants associated ... [+]
Cutaneous melanoma is the most aggressive of skin tumors. In order to discover new
biomarkers that could help us improve prognostic prediction in melanoma patients, we have searched
for germline DNA variants associated with melanoma progression. Thus, after exome sequencing of
a set of melanoma patients and healthy control individuals, we identified rs1042602, an SNP within
TYR, as a good candidate. After genotyping rs1042602 in 1025 patients and 773 healthy donors, we
found that the rs1042602-A allele was significantly associated with susceptibility to melanoma (CATT
test: p = 0.0035). Interestingly, we also observed significant differences between patients with good
and bad prognosis (5 years of follow-up) (n = 664) (CATT test for all samples p = 0.0384 and for men
alone p = 0.0054). Disease-free-survival (DFS) analyses also showed that patients with the A allele
had shorter DFS periods. In men, the association remained significant even in a multivariate Cox
Proportional-hazards model, which was adjusted for age at diagnosis, Breslow thickness, ulceration
and melanoma subtype (HR 0.4; 95% confidence interval (CI) 0.20–0.83; p = 0.0139). Based on our
results, we propose that rs1042602-A is a risk allele for melanoma, which also seems to be responsible
for a poorer prognosis of the disease, particularly in men. [-]
Publicado en
Life, 2022, 12, 2004.Entidad financiadora
Gobierno Vasco | Universidad del País Vasco
Código del proyecto o subvención
KK2017-041 | KK2020-00069 | IT1693-22 | GIU17/066 | PCIN-2015-241
Derechos de acceso
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [639]
Excepto si se señala otra cosa, la licencia del ítem se describe como: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).